<DOC>
	<DOCNO>NCT00091169</DOCNO>
	<brief_summary>RATIONALE : Levocarnitine may help improve energy level cancer patient . PURPOSE : This randomized phase III trial study well levocarnitine work compare placebo treat fatigue cancer patient .</brief_summary>
	<brief_title>Levocarnitine Treating Fatigue Cancer Patients</brief_title>
	<detailed_description>OBJECTIVES : Primary Objective : - Compare efficacy levocarnitine ( L-carnitine ) supplementation v placebo management fatigue patient cancer . Secondary Objectives : - Assess effect levocarnitine pain , depression performance status 4 8 week follow-up . - Determine prevalence serum carnitine deficiency patient treat regimen . - Explore association carnitine deficiency fatigue . - Present toxicity profile patient . Correlative Objective : - Measure serum level pro-inflammatory cytokine growth factor correlate fatigue onco-behavioral symptom . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord gender , ECOG performance status ( 0-1 v 2-3 ) , concurrent chemotherapy ( yes v ) . Patients randomize 1 2 treatment arm 1:1 ratio . - Arm I ( levocarnitine ) : Patients receive oral levocarnitine ( L-carnitine ) twice daily ( 2000 mg/day ) week 1-4 . - Arm II ( placebo ) : Patients receive oral placebo twice daily ( 2000 mg/day ) week 1-4 . The dose titrated 2-day period ( i.e . two 500 mg dos first day two 1000 mg dos second day ) avoid gastrointestinal side effect . Patients continue receive two daily dos 1000 mg day 3 28 . After week 4 , patient ( arm ) receive open-label oral L-carnitine twice daily week 5-8 ( extension phase ) administer fashion first 4 week . For patient receive dose modification week 1 4 , receive reduce dose extension phase ( without titration ) Fatigue , pain , depression assess baseline week 4 8 . PROJECTED ACCRUAL : A total 352 patient accrue study .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Diagnosis invasive malignant disorder Moderate severe fatigue within past 4 week , define score â‰¥ 2 ( scale 04 ) Functional Assessment Chronic Illness TherapyFatigue ( FACITF ) question `` I feel fatigue '' Age 18 Eastern Cooperative Oncology Group ( ECOG ) Performance status 03 Negative pregnancy test Fertile patient must use effective contraception 3 month study participation Brain metastases Hemoglobin &lt; 9 g/dL , take &lt; =4 week prior registration Severe , uncontrolled liver disease Evidence severely compromise renal function include 1 following : Renal failure End stage renal disease Ongoing renal dialysis Severe , uncontrolled cardiovascular disease Severe , uncontrolled pulmonary disease Pregnant nursing History seizures Known sensitivity carnitine Delirium Nausea &gt; grade 1 Taking form levocarnitine ( Lcarnitine ) supplementation nutritional supplement contain carnitine within 2 month prior registration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>fatigue</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>levocarnitine</keyword>
	<keyword>depression</keyword>
	<keyword>pain</keyword>
	<keyword>carnitine deficiency</keyword>
</DOC>